G1 Therapeutics Inc (GTHX)
7.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
G1 Therapeutics Total Liabilities (Quarterly): 74.10M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 74.10M |
| March 31, 2024 | 74.29M |
| December 31, 2023 | 86.15M |
| September 30, 2023 | 90.08M |
| June 30, 2023 | 90.34M |
| March 31, 2023 | 116.97M |
| December 31, 2022 | 119.22M |
| September 30, 2022 | 120.61M |
| June 30, 2022 | 120.55M |
| March 31, 2022 | 118.11M |
| December 31, 2021 | 110.55M |
| September 30, 2021 | 65.16M |
| June 30, 2021 | 63.56M |
| March 31, 2021 | 63.12M |
| December 31, 2020 | 51.20M |
| September 30, 2020 | 60.76M |
| Date | Value |
|---|---|
| June 30, 2020 | 49.75M |
| March 31, 2020 | 27.06M |
| December 31, 2019 | 29.30M |
| September 30, 2019 | 31.07M |
| June 30, 2019 | 18.98M |
| March 31, 2019 | 12.73M |
| December 31, 2018 | 12.45M |
| September 30, 2018 | 13.76M |
| June 30, 2018 | 14.08M |
| March 31, 2018 | 12.59M |
| December 31, 2017 | 11.78M |
| September 30, 2017 | 10.42M |
| June 30, 2017 | 10.41M |
| March 31, 2017 | 8.296M |
| December 31, 2016 | 5.625M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
27.06M
Minimum
Mar 2020
120.61M
Maximum
Sep 2022
80.57M
Average
74.29M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| PetIQ Inc | 634.08M |
| Biomarin Pharmaceutical Inc | 1.438B |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Verrica Pharmaceuticals Inc | 66.98M |
| Terns Pharmaceuticals Inc | 12.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.69M |
| Shareholders Equity (Quarterly) | 24.59M |
| Debt to Equity Ratio | 1.802 |
| Current Ratio | 2.478 |
| Net Debt Paydown Yield | 5.52% |